When SUM159 tumor cells were co-transplanted with primary human monocytes for 21 days, these monocyte-derived TAMs upregulated CD169 and potentially co-expressed PDL1 (Figures 2A, B right), indicating that human CD169+ TAMs can be monocyte-derived. This evidence concerns the gene SIGLEC1 and neoplasm.